| Literature DB >> 8365475 |
E Gandini1, P Orlando, R Selvatici, A Balboni, S Boninsegna, M Rubini.
Abstract
A peptide inhibiting either corpuscolate or purified PKC has been identified from microsomes of PHA-activated human PBMC but it is not detectable in microsomes of resting PBMC. The peptide was obtained from a microsomal preparation in an oligomeric form that could be transformed into a monomeric form by beta-MSH. The active peptide (IN) was retained on a PC-11 chromatographic column and could be eluted with NaCl. IN is ineffective on PKC-dependent protamine phosphorylation of protamine and on Ca2+ and phospholipid-independent activity generated by mild hydrolysis with trypsin of PKC. Ca2+ binding is permissive for IN activity. IN inhibits particulate PKC in PHA-activated PBMC, but is ineffective after TPA activation. All these data indicate that IN acts at the regulatory domain of PKC.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8365475 DOI: 10.1016/0014-5793(93)80246-q
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124